Gynecologic cancer in pregnancy.
Korenaga TK, Tewari KS.
Gynecol Oncol. 2020 Jun;157(3):799-809. doi: 10.1016/j.ygyno.2020.03.015. Epub 2020 Apr 5.
A child presenting with bullous emphysema.
Özsezen B, Tural DA, Üner M, Özcan HN, Nurullayev E, Emiralioğlu N, Soyer T, Orhan D, Yalçın E, Doğru D, Özçelik U, Kiper N.
Turk J Pediatr. 2022;64(5):964-969. doi: 10.24953/turkjped.2021.5515.
Infertility as a cancer risk factor - a review.
Cetin I, Cozzi V, Antonazzo P.
Placenta. 2008 Oct;29 Suppl B:169-77. doi: 10.1016/j.placenta.2008.08.007.
A brief history of the pathology of the gonads.
Young RH.
Mod Pathol. 2005 Feb;18 Suppl 2:S3-S17. doi: 10.1038/modpathol.3800305.
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B, Taube A, Lindgren A, Sjöberg O, Stendahl U, Kiviranta A, Hallman K, Holm L, Weiner E, Tamsen L.
Gynecol Oncol. 1990 Oct;39(1):16-25. doi: 10.1016/0090-8258(90)90393-y.
A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells.
Zhang W, Yang H, Zhang Y, Lu Y, Zhou T, Li M, Wen Y, Lin X, Xiang R, Chen X.
Oncotarget. 2015 Dec 1;6(38):40762-74. doi: 10.18632/oncotarget.5691.
Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.
Matsukawa T, Mizutani S, Matsumoto K, Kato Y, Yoshihara M, Kajiyama H, Shibata K.
J Clin Med. 2021 Dec 31;11(1):222. doi: 10.3390/jcm11010222.
Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line.
Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS.
Cell Growth Differ. 1994 Nov;5(11):1173-83.
Localization of the steroidogenic acute regulatory protein in human tissues.
Pollack SE, Furth EE, Kallen CB, Arakane F, Kiriakidou M, Kozarsky KF, Strauss JF 3rd.
J Clin Endocrinol Metab. 1997 Dec;82(12):4243-51. doi: 10.1210/jcem.82.12.4445.
H-RYK, an unusual receptor kinase: isolation and analysis of expression in ovarian cancer.
Wang XC, Katso R, Butler R, Hanby AM, Poulsom R, Jones T, Sheer D, Ganesan TS.
Mol Med. 1996 Mar;2(2):189-203.
